Discharge Diagnosis

General Details:

Name:
Discharge Diagnosis
Steward:
Project 5 (COVID-19)
Definition:
Diagnosis upon discharge from the hospital.
Registration Status:
Qualified

Permissible Values:

Data Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Positive COVID-19 lab result An indication that SARS coronavirus 2 has been detected in a sample. C171647
COVID-19, virus identified A positive-sense single-stranded RNA virus in the genus Beta coronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:The procedure of having an identity established. C169076:C25737
SARS-associated coronavirus as etiology A species of enveloped, spherical or pleomorphic, kidney-shaped or rod-shaped viruses in the Coronaviridae family and Coronavirus genus. The genome is composed of linear, single-stranded, positive-sense RNA. SARS coronaviruses are found in humans and cause severe acute respiratory syndrome (SARS). SARS coronaviruses are transmitted via direct person-to-person contact with infected secretions or excretions, and aerosols of respiratory droplets.:In the same amount or manner; to the same degree; in the role, function, or capacity of.:The cause of a disease or abnormal condition. C112432:C64938:C16390
Other coronavirus as etiology Different than the one(s) previously specified or mentioned.:A genus of single-stranded, positive-sense RNA viruses in the family coronaviridae. The coronavirus genome exhibits helical symmetry.:In the same amount or manner; to the same degree; in the role, function, or capacity of.:The cause of a disease or abnormal condition. C17649:C26431:C64938:C16390
COVID-19 Associated Pneumonia Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is characterized by the presence of ground glass opacities on CT scan images. C171550
COVID-19 infection An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction. C171133
Acute COVID Having a severe and rapid onset of symptoms with short duration.:An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction. C14140:C171133
MIS-C A rare syndrome temporally associated with COVID-19 in children, marked by persistent fever, inflammation (neutrophilia, elevated C-reactive protein (CRP), and lymphopenia), poor function in one or more organs, and other specific clinical and laboratory features not attributable to other infections. The characteristics of this syndrome appear to be similar to toxic shock syndrome and Kawasaki disease. The following variable signs and symptoms have been most commonly reported to date: coagulopathy, cardiac dysfunction, diarrhea, abdominal distension, other GI symptoms (with some children having positive stool tests for SARS-CoV-2), and acute kidney injury. Respiratory symptoms are not always a prominent feature in these cases. C172127
Kawasaki Disease A vasculitis characterized by inflammation of the arteries, particularly the coronary arteries. The vasculitis may lead to aneurysm formation and possibly, heart attacks. It affects young children who usually present with persistent high fever, redness of the mucous membranes of the mouth, redness of the palms and soles, skin rashes, lymphadenitis, and joint pain and swelling. C34825
Long COVID/PASC A constellation of signs and symptoms that can persist for weeks or months after acute infection with SARS-CoV-2, or appear weeks after infection. This condition may be characterized by fatigue, shortness of breath, difficulty focusing or concentrating ("brain fog"), sleep disorders, fevers, gastrointestinal symptoms, anxiety, and depression. C179263
Not Available/Unknown The desired information is not available.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Not known, observed, recorded; or reported as unknown by the data contributor. C126101:C37998:C17998
Other, Specify A directive to specify when the listed responses are not sufficient. C157101

Designations:

Designation:
Discharge Diagnosis
Tags:
Designation:
What was the discharge diagnosis?
Tags:
Preferred Question Text

Designations:

Definition:
Diagnosis upon discharge from the hospital.
Tags:

Properties:

Key:
Tags/Keywords
Value:
COVID Specific, Discharge Information, Hospitalization
Key:
Project 5 (COVID-19) Source
Value:
Project 5 WG2

Identifiers:

Source:
NLM
Id:
I75TihEyc
Version: